Adolescent Oral Contraceptive Use Tied to Later Depression Risk
Findings show long-term impact, regardless of current oral contraception use in adulthood.
Contraception
Oral Contraceptive Recalled Due to Possibility of Reduced Efficacy
Jubilant Cadista Pharmaceuticals is recalling 1 lot of the combination oral contraceptive Drospirenone and Ethinyl Estradiol Tablets, USP, 3mg/0.02mg due to the possibility of decreased product efficacy.
HIV Risk Does Not Differ With 3 Contraceptive Methods
No significant difference seen with use of DMPA-IM, copper IUD device, levonorgestrel implant in African women.
Oral Contraceptive Pill May Protect Against ACL Tears
Risk for acute cruciate ligament reconstruction reduced while on OCP, especially for 15- to 19-year-olds.
Oral Contraceptives Offer Some Protection Against Bone Loss in Anorexia Nervosa
For young women with anorexia nervosa, oral contraceptives may limit bone loss.
Novel Androgen May Be a Potential Candidate for Male Hormonal Contraceptive
11β-MNTDC is a modified testosterone with androgenic and progestational activity that is being developed as a potential male contraceptive.
Delayed Contraception Leads to Early Unwanted Pregnancy
More African-American, Hispanic, low-income respondents report delayed contraceptive initiation.
CDC: 65% of US Women Currently Using Contraceptives
Female sterilization is most commonly used method, followed by oral contraceptive pill.
Study Finds Intrauterine Levonorgestrel Contraceptive System Safe, Effective
A levonorgestrel 52-mg intrauterine system was found to be safe and effective for pregnancy prevention.
Trump Administration Finalizes Birth Control Coverage Opt-Out
A birth control coverage opt-out for employers was finalized by the Trump administration on Wednesday.
Next post in Practice Management Information Center
